Stevanato Group S.p.A (STVN) Income from Continuing Operations (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Income from Continuing Operations came in at 32812488.33 in Q1 2026, up 17.65% year-on-year from 27889664.03 in Q1 2025, and down 40.78% on a QoQ basis from 55408471.3 in Q4 2025.
Stevanato Group S.p.A (STVN) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Income from Continuing Operations data on file, last reported at 32812488.33 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 17.65% year-over-year to 32812488.33 in Q1 2026; TTM through Mar 2026 was 163998627.07, a 21.74% increase from a year earlier, with the FY2025 full-year figure at 162733283.35, up 29.28% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 32812488.33, down from 55408471.3 in the prior quarter.
- Over the last five years, Income from Continuing Operations for STVN reached as high as 55408471.3 in Q4 2025 and fell as low as 20436637.56 in Q1 2024.
- Historically, Income from Continuing Operations has averaged 36850331.65 across 5 years, with a median of 33619202.73 in 2025.
- Across the five-year window, Income from Continuing Operations soared 66.63% in 2022 and slumped 40.42% in 2024, its largest moves.
- Year by year, Income from Continuing Operations stood at 49277947.74 in 2022, then slipped by 1.31% to 48632483.89 in 2023, then advanced by 6.13% to 51613157.83 in 2024, then grew by 7.35% to 55408471.3 in 2025, then plunged by 40.78% to 32812488.33 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 32812488.33 in Q1 2026, 55408471.3 in Q4 2025, and 42158464.7 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Stevanato Group S.p.A | 5.29 Bn | 5.15 Bn | 88.01 Mn | 32.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.81 Mn |
| Dec 31, 2025 | 55.41 Mn |
| Sep 30, 2025 | 42.16 Mn |
| Jun 30, 2025 | 33.62 Mn |
| Mar 31, 2025 | 27.89 Mn |
| Dec 31, 2024 | 51.61 Mn |
| Sep 30, 2024 | 32.95 Mn |
| Jun 30, 2024 | 22.26 Mn |
| Mar 31, 2024 | 20.44 Mn |
| Dec 31, 2023 | 48.63 Mn |
| Sep 30, 2023 | 41.26 Mn |
| Jun 30, 2023 | 37.36 Mn |
| Mar 31, 2023 | 30.36 Mn |
| Dec 31, 2022 | 49.28 Mn |
| Sep 30, 2022 | 36.59 Mn |
| Jun 30, 2022 | 32.68 Mn |
| Mar 31, 2022 | 31.16 Mn |
| Dec 31, 2021 | 51.02 Mn |
| Sep 30, 2021 | 21.96 Mn |
| Jun 30, 2021 | 41.55 Mn |